BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang K, Chen D, Ma K, Wu X, Hao H, Jiang S. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer. J Med Chem 2018;61:6983-7003. [DOI: 10.1021/acs.jmedchem.8b00124] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu H, Gao HY, Guo H, Wang GZ, Yang YQ, Hu Q, Liang LJ, Zhao Q, Xie DW, Rao Y, Zhou GB. Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells. Acta Pharmacol Sin 2021. [PMID: 34035487 DOI: 10.1038/s41401-021-00691-8] [Reference Citation Analysis]
2 Chen Y, Zhao X, Xiong T, Du J, Sun W, Fan J, Peng X. NIR photosensitizers activated by γ-glutamyl transpeptidase for precise tumor fluorescence imaging and photodynamic therapy. Sci China Chem 2021;64:808-16. [DOI: 10.1007/s11426-020-9947-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
3 Zhong B, Yu J, Hou Y, Ai N, Ge W, Lu JJ, Chen X. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. Free Radic Biol Med 2021;166:104-15. [PMID: 33600944 DOI: 10.1016/j.freeradbiomed.2021.02.014] [Reference Citation Analysis]
4 Wang XW, Tian RM, Yang YQ, Lu ZY, Han XD, Liu XS, Mao W, Xu P, Xu HT, Liu B. Triptriolide antagonizes triptolide-induced nephrocyte apoptosis via inhibiting oxidative stress in vitro and in vivo. Biomed Pharmacother 2019;118:109232. [PMID: 31369987 DOI: 10.1016/j.biopha.2019.109232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
5 Karpaga Raja Sundari B, Budhwar R, Dwarakanath BS, Thyagarajan SP. De novo transcriptome analysis unravels tissue-specific expression of candidate genes involved in major secondary metabolite biosynthetic pathways of Plumbago zeylanica: implication for pharmacological potential. 3 Biotech 2020;10:271. [PMID: 32523865 DOI: 10.1007/s13205-020-02263-9] [Reference Citation Analysis]
6 Varlet T, Gelis C, Retailleau P, Bernadat G, Neuville L, Masson G. Enantioselective Redox-Divergent Chiral Phosphoric Acid Catalyzed Quinone Diels-Alder Reactions. Angew Chem Int Ed Engl 2020;59:8491-6. [PMID: 32112662 DOI: 10.1002/anie.202000838] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
7 Wu L, Ma X, Yang X, Zhang C. Synthesis and biological evaluation of β-lapachone-monastrol hybrids as potential anticancer agents. European Journal of Medicinal Chemistry 2020;203:112594. [DOI: 10.1016/j.ejmech.2020.112594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang L, Zhang G, Xu S, Song Y. Recent advances of quinones as a privileged structure in drug discovery. Eur J Med Chem 2021;223:113632. [PMID: 34153576 DOI: 10.1016/j.ejmech.2021.113632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cheng Z, Valença WO, Dias GG, Scott J, Barth ND, de Moliner F, Souza GBP, Mellanby RJ, Vendrell M, da Silva Júnior EN. Natural product-inspired profluorophores for imaging NQO1 activity in tumour tissues. Bioorg Med Chem 2019;27:3938-46. [PMID: 31327676 DOI: 10.1016/j.bmc.2019.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
10 Wu LQ, Ma X, Liu ZP. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents. Bioorg Chem 2021;113:104995. [PMID: 34034133 DOI: 10.1016/j.bioorg.2021.104995] [Reference Citation Analysis]
11 Shreevatsa B, Dharmashekara C, Swamy VH, Gowda MV, Achar RR, Kameshwar VH, Thimmulappa RK, Syed A, Elgorban AM, Al-Rejaie SS, Ortega-Castro J, Frau J, Flores-Holguín N, Shivamallu C, Kollur SP, Glossman-Mitnik D. Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy. Molecules 2021;26:6863. [PMID: 34833955 DOI: 10.3390/molecules26226863] [Reference Citation Analysis]
12 Lundberg AP, Boudreau MW, Selting KA, Chatkewitz LE, Samuelson J, Francis JM, Parkinson EI, Barger AM, Hergenrother PJ, Fan TM. Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy. Neoplasia 2021;23:811-22. [PMID: 34246985 DOI: 10.1016/j.neo.2021.06.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhao W, Jiang L, Fang T, Fang F, Liu Y, Zhao Y, You Y, Zhou H, Su X, Wang J, Liu S, Chen Y, Wan J, Huang X. β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation. Front Oncol 2021;11:747282. [PMID: 34676172 DOI: 10.3389/fonc.2021.747282] [Reference Citation Analysis]
14 Wu L, Ma X, Zhang C, Liu Z. Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents. European Journal of Medicinal Chemistry 2020;198:112396. [DOI: 10.1016/j.ejmech.2020.112396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Zheng Y, Pan D, Zhang Y, Zhang Y, Shen Y. Hemicyanine-based near-infrared fluorescent probe for the ultrasensitive detection of hNQO1 activity and discrimination of human cancer cells. Analytica Chimica Acta 2019;1090:125-32. [DOI: 10.1016/j.aca.2019.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Khasiyatullina NR, Mironov VF, Voloshina AD, Sapunova AS. Synthesis and Antimicrobial Properties of Novel Phosphonium Salts Bearing 1,4-Dihydroxyaryl Fragment. Chem Biodivers 2019;16:e1900039. [PMID: 30817850 DOI: 10.1002/cbdv.201900039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Yang Y, Zheng J, Wang M, Zhang J, Tian T, Wang Z, Yuan S, Liu L, Zhu P, Gu F, Fu S, Shan Y, Pan Z, Zhou W. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling. Cancer Sci 2021;112:641-54. [PMID: 33222332 DOI: 10.1111/cas.14744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Yu J, Zhong B, Zhao L, Hou Y, Wang X, Chen X. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1). Free Radic Biol Med 2021;173:64-9. [PMID: 34252539 DOI: 10.1016/j.freeradbiomed.2021.07.017] [Reference Citation Analysis]
19 Modranka J, Drogosz-Stachowicz J, Pietrzak A, Janecka A, Janecki T. Synthesis and structure-activity relationship study of novel 3-diethoxyphosphorylfuroquinoline-4,9-diones with potent antitumor efficacy. Eur J Med Chem 2021;219:113429. [PMID: 33852973 DOI: 10.1016/j.ejmech.2021.113429] [Reference Citation Analysis]
20 Li Q, Jin Y, Shen Z, Liu H, Shen Y, Wu Z. Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction. Int J Gen Med 2021;14:10117-29. [PMID: 34992433 DOI: 10.2147/IJGM.S343233] [Reference Citation Analysis]
21 Walia HK, Singh N, Sharma S. Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Per Med 2021;18:333-46. [PMID: 33973803 DOI: 10.2217/pme-2020-0119] [Reference Citation Analysis]
22 Preethi S, Arthiga K, Patil AB, Spandana A, Jain V. Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway. Mol Biol Rep 2022. [PMID: 35347544 DOI: 10.1007/s11033-022-07369-2] [Reference Citation Analysis]
23 Patiño-García A, Guruceaga E, Segura V, Sánchez Bayona R, Andueza MP, Tamayo Uria I, Serrano G, Fusco JP, Pajares MJ, Gurpide A, Ocón M, Sanmamed MF, Rodriguez Ruiz M, Melero I, Lozano MD, de Andrea C, Pita G, Gonzalez-Neira A, Gonzalez A, Zulueta JJ, Montuenga LM, Pio R, Perez-Gracia JL. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma. Transl Lung Cancer Res 2021;10:1327-37. [PMID: 33889513 DOI: 10.21037/tlcr-20-1197] [Reference Citation Analysis]
24 Cheng ST, Hu JL, Ren JH, Yu HB, Zhong S, Wai Wong VK, Kwan Law BY, Chen WX, Xu HM, Zhang ZZ, Cai XF, Hu Y, Zhang WL, Long QX, Ren F, Zhou HZ, Huang AL, Chen J. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. J Hepatol. 2021;74:522-534. [PMID: 32987030 DOI: 10.1016/j.jhep.2020.09.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
25 Qu Y, Zhang C, Ma X, Gao Y, Liu J, Wu L. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents. Bioorg Med Chem 2020;28:115821. [PMID: 33091789 DOI: 10.1016/j.bmc.2020.115821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, Yu AM, Zuo Z, Bi H. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B 2019;9:1113-44. [PMID: 31867160 DOI: 10.1016/j.apsb.2019.10.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
27 Yan D, Xu X, Ren C, Chen C, Luo J, Han C, Kong L. DT-diaphorase triggered theranostic nanoparticles induce the self-burst of reactive oxygen species for tumor diagnosis and treatment. Acta Biomater 2021;125:267-79. [PMID: 33652166 DOI: 10.1016/j.actbio.2021.02.033] [Reference Citation Analysis]
28 Hajj GNM, Nunes PBC, Roffe M. Genome-wide translation patterns in gliomas: An integrative view. Cell Signal 2021;79:109883. [PMID: 33321181 DOI: 10.1016/j.cellsig.2020.109883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
29 Tsao YC, Chang YJ, Wang CH, Chen L. Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone. Int J Mol Sci 2020;21:E4378. [PMID: 32575541 DOI: 10.3390/ijms21124378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Gong Q, Yu Q, Wang N, Hu J, Wang P, Yang F, Li T, You Q, Li X, Zhang X. Application of cation-π interactions in enzyme-substrate binding: Design, synthesis, biological evaluation, and molecular dynamics insights of novel hydrophilic substrates for NQO1. Eur J Med Chem 2021;221:113515. [PMID: 33984806 DOI: 10.1016/j.ejmech.2021.113515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Xin F, Wu M, Cai Z, Zhang X, Wei Z, Liu X, Liu J. Tumor Microenvironment Triggered Cascade-Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma. Adv Healthc Mater 2021;10:e2002036. [PMID: 33644987 DOI: 10.1002/adhm.202002036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gong Q, Yang F, Hu J, Li T, Wang P, Li X, Zhang X. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics. Eur J Med Chem 2021;224:113707. [PMID: 34303080 DOI: 10.1016/j.ejmech.2021.113707] [Reference Citation Analysis]
33 Lee KM, Gwon MR, Lee HW, Seong SJ, Yoon YR. The possibility of low isomerization of β-lapachone in the human body. Transl Clin Pharmacol 2021;29:160-70. [PMID: 34621708 DOI: 10.12793/tcp.2021.29.e16] [Reference Citation Analysis]
34 Ogiso T, Fukami T, Zhongzhe C, Konishi K, Nakano M, Nakajima M. Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid. Toxicology 2021;448:152648. [PMID: 33259822 DOI: 10.1016/j.tox.2020.152648] [Reference Citation Analysis]
35 Hou W, Liu B, Xu H. Triptolide: Medicinal chemistry, chemical biology and clinical progress. European Journal of Medicinal Chemistry 2019;176:378-92. [DOI: 10.1016/j.ejmech.2019.05.032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
36 Jin H, Cui M. Recognition of potential therapeutic role of 2-hydroxy-3-methylanthraquinones in the treatment of gallbladder carcinoma: A proteomics analysis. Fundam Clin Pharmacol 2021. [PMID: 34850442 DOI: 10.1111/fcp.12740] [Reference Citation Analysis]
37 Chen L, Xie Y, Luo Z, Liu L, Zou Z, Liu H, Kong F, Hao Y, Gao J, Wang L, Ma D, Liu S. Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues. Bioorganic & Medicinal Chemistry Letters 2020;30:127286. [DOI: 10.1016/j.bmcl.2020.127286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Singh N, Pay SL, Bhandare SB, Arimpur U, Motea EA. Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy. Cancers (Basel) 2020;12:E972. [PMID: 32295316 DOI: 10.3390/cancers12040972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Khunluck T, Kukongviriyapan V, Senggunprai L, Duangarsong W, Prawan A. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells. Integr Cancer Ther 2019;18:1534735418820444. [PMID: 30584780 DOI: 10.1177/1534735418820444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Han J, Cheng L, Zhu Y, Xu X, Ge C. Covalent-Assembly Based Fluorescent Probes for Detection of hNQO1 and Imaging in Living Cells. Front Chem 2020;8:756. [PMID: 33005608 DOI: 10.3389/fchem.2020.00756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wang K, Yang B, Ye H, Zhang X, Song H, Wang X, Li N, Wei L, Wang Y, Zhang H, Kan Q, He Z, Wang D, Sun J. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer. ACS Appl Mater Interfaces 2019;11:18914-22. [PMID: 31055911 DOI: 10.1021/acsami.9b03056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
42 Dai M, Song CW, Yang YJ, Kim HR, Reo YJ, Ahn KH. Toward Ratiometric Detection of NAD(P)H Quinone Oxidoreductase-1: Benzocoumarin-Based Fluorescent Probes. Sensors and Actuators B: Chemical 2021;330:129277. [DOI: 10.1016/j.snb.2020.129277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Jiang X, Zhou X, Yu X, Chen X, Hu X, Lu J, Zhao H, Cao Q, Gu Y, Yang Y, Jiang W, Jin M. High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients. Mod Pathol 2022. [PMID: 35194221 DOI: 10.1038/s41379-022-01010-0] [Reference Citation Analysis]
44 Smolyaninov IV, Burmistrova DA, Arsenyev MV, Almyasheva NR, Ivanova ES, Smolyaninova SA, Pashchenko KP, Poddel'sky AI, Berberova NT. Catechol‐ and Phenol‐Containing Thio‐Schiff Bases: Synthesis, Electrochemical Properties and Biological Evaluation. ChemistrySelect 2021;6:10609-18. [DOI: 10.1002/slct.202102246] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Punganuru SR, Madala HR, Arutla V, Srivenugopal KS. Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo. Cancers (Basel) 2018;10:E470. [PMID: 30487423 DOI: 10.3390/cancers10120470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
46 Chhour M, Perio P, Gayon R, Ternet-Fontebasso H, Ferry G, Nepveu F, Boutin JA, Sudor J, Reybier K. Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells. Front Pharmacol 2021;12:660641. [PMID: 34040527 DOI: 10.3389/fphar.2021.660641] [Reference Citation Analysis]
47 Sweeney M, Conboy D, Mirallai SI, Aldabbagh F. Advances in the Synthesis of Ring-Fused Benzimidazoles and Imidazobenzimidazoles. Molecules 2021;26:2684. [PMID: 34064312 DOI: 10.3390/molecules26092684] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Sidhu JS, Kaur N, Singh N. Trends in small organic fluorescent scaffolds for detection of oxidoreductase. Biosens Bioelectron 2021;191:113441. [PMID: 34167075 DOI: 10.1016/j.bios.2021.113441] [Reference Citation Analysis]
49 Bakalova R, Semkova S, Ivanova D, Zhelev Z, Miller T, Takeshima T, Shibata S, Lazarova D, Aoki I, Higashi T. Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant. Oxid Med Cell Longev 2020;2020:6212935. [PMID: 33204397 DOI: 10.1155/2020/6212935] [Reference Citation Analysis]
50 Zhang R, Tu J, Liu S. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity. Semin Cancer Biol 2021:S1044-579X(21)00058-4. [PMID: 33737107 DOI: 10.1016/j.semcancer.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Zhou M, Xie Y, Xu S, Xin J, Wang J, Han T, Ting R, Zhang J, An F. Hypoxia-activated nanomedicines for effective cancer therapy. Eur J Med Chem 2020;195:112274. [PMID: 32259703 DOI: 10.1016/j.ejmech.2020.112274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
52 Wu Z, Wang Q, Yang H, Wang J, Li W, Liu G, Yang Y, Zhao Y, Tang Y. Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures. J Chem Inf Model 2021;61:2486-98. [PMID: 33955748 DOI: 10.1021/acs.jcim.1c00260] [Reference Citation Analysis]
53 Digby EM, Sadovski O, Beharry AA. An Activatable Photosensitizer Targeting Human NAD(P)H: Quinone Oxidoreductase 1. Chemistry 2020;26:2713-8. [PMID: 31814180 DOI: 10.1002/chem.201904607] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
54 Li H, Kim H, Xu F, Han J, Yao Q, Wang J, Pu K, Peng X, Yoon J. Activity-based NIR fluorescent probes based on the versatile hemicyanine scaffold: design strategy, biomedical applications, and outlook. Chem Soc Rev 2022. [PMID: 35142301 DOI: 10.1039/d1cs00307k] [Reference Citation Analysis]
55 Yang X, Duan J, Wu L. Research advances in NQO1-responsive prodrugs and nanocarriers for cancer treatment. Future Med Chem 2022. [PMID: 35102756 DOI: 10.4155/fmc-2021-0289] [Reference Citation Analysis]
56 Conboy D, Mirallai SI, Craig A, McArdle P, Al-Kinani AA, Barton S, Aldabbagh F. Incorporating Morpholine and Oxetane into Benzimidazolequinone Antitumor Agents: The Discovery of 1,4,6,9-Tetramethoxyphenazine from Hydrogen Peroxide and Hydroiodic Acid-Mediated Oxidative Cyclizations. J Org Chem 2019;84:9811-8. [PMID: 31293163 DOI: 10.1021/acs.joc.9b01427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zhang C, Qu Y, Ma X, Li M, Li S, Li Y, Wu L. NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation. Bioorganic Chemistry 2020;103:104200. [DOI: 10.1016/j.bioorg.2020.104200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Yang Y, Qi F, Qian Y, Bao X, Zhang H, Ma B, Dai F, Zhang S, Zhou B. Developing Push–Pull Hydroxylphenylpolyenylpyridinium Chromophores as Ratiometric Two-Photon Fluorescent Probes for Cellular and Intravital Imaging of Mitochondrial NQO1. Anal Chem 2021;93:2385-93. [DOI: 10.1021/acs.analchem.0c04279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Aregbesola OA, Kumar A, Mokoena MP, Olaniran AO. Role of tetrachloro-1,4-benzoquinone reductase in phenylalanine hydroxylation system and pentachlorophenol degradation in Bacillus cereus AOA-CPS1. Int J Biol Macromol 2020;161:875-90. [PMID: 32535205 DOI: 10.1016/j.ijbiomac.2020.06.083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Lin LC, Lee HT, Chien PJ, Huang YH, Chang MY, Lee YC, Chang WW. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1. Int J Med Sci 2020;17:2214-24. [PMID: 32922184 DOI: 10.7150/ijms.45706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]